Dj. Nikolicpaterson et al., SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY THE INTERLEUKIN-1 RECEPTOR ANTAGONIST - INHIBITION OF INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION, Journal of the American Society of Nephrology, 4(9), 1994, pp. 1695-1700
Interleukin-1 is a proinflammatory cytokine produced in glomerulonephr
itis. Blocking the action of interleukin-1 by the administration of th
e interleukin-1 receptor antagonist (IL-1ra) has been shown to prevent
renal function impairment, reduce glomerular injury, inhibit leukocyt
e infiltration, and suppress tubulointerstitial damage in experimental
antiglomerular basement membrane disease. A key mechanism in the entr
y of leukocytes into the kidney is the interaction between the interle
ukin-1 inducible intercellular adhesion molecule-1 (ICAM-1; CD54) and
lymphocyte function-associated antigen-1 (CD11a/CD18). Therefore, this
study investigated whether the inhibition of this mechanism was the m
eans by which IL-1ra suppressed leukocyte infiltration in rat accelera
ted antiglomerular basement membrane glomerulonephritis. Disease was i
nduced in two groups of six rats; animals were treated by constant sc
infusion of recombinant human IL-1ra or saline from the initiation of
disease until being euthanized 14 days later. In saline-treated animal
s, there was marked up-regulation of ICAM-1 in the glomerulus and inte
rstitium, which was associated with leukocyte infiltration. In particu
lar, focal accumulation of CD1 1a(+) and CD18(+) cells was apparent in
areas of tubulointerstitial damage exhibiting intense ICAM-1 expressi
on. IL-1ra treatment partially reduced glomerular ICAM-1 expression an
d leukocyte infiltration. However, IL-1ra treatment resulted in a dram
atic inhibition of interstitial ICAM-1 expression, interstitial leukoc
yte infiltration, and tubulointerstitial damage. In conclusion, this s
tudy has shown that interleukin-1 is a major inducer of ICAM-1 express
ion within the renal tubulointerstitium-a process associated with foca
l leukocyte infiltration and tubulointerstitial damage. This is the fi
rst demonstration of a specific mechanism by which interleukin-1 parti
cipates in the pathogenesis of renal injury.